Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Weak protein-cationic co-ion interactions addressed by X-ray crystallography and mass spectrometry.

Bénas P, Auzeil N, Legrand L, Brachet F, Regazzetti A, Riès-Kautt M.

Acta Crystallogr D Biol Crystallogr. 2014 Aug;70(Pt 8):2217-31. doi: 10.1107/S1399004714011304. Epub 2014 Jul 25.

PMID:
25084340
2.

Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.

Guénard S, Muller C, Monlezun L, Benas P, Broutin I, Jeannot K, Plésiat P.

Antimicrob Agents Chemother. 2014;58(1):221-8. doi: 10.1128/AAC.01252-13. Epub 2013 Oct 21. Erratum in: Antimicrob Agents Chemother. 2014 Mar;58(3):1833.

3.

Stoichiometry of the MexA-OprM binding, as investigated by blue native gel electrophoresis.

Ferrandez Y, Monlezun L, Phan G, Benabdelhak H, Benas P, Ulryck N, Falson P, Ducruix A, Picard M, Broutin I.

Electrophoresis. 2012 Apr;33(8):1282-7. doi: 10.1002/elps.201100541.

PMID:
22589107
4.

Activity monitoring of functional OprM using a biomimetic microfluidic device.

Wang W, Monlezun L, Picard M, Benas P, Français O, Broutin I, Le Pioufle B.

Analyst. 2012 Feb 21;137(4):847-52. doi: 10.1039/c2an16007b. Epub 2012 Jan 4.

PMID:
22215439
5.

Synchrotron x-ray microdiffraction reveals intrinsic structural features of amyloid deposits in situ.

Briki F, Vérine J, Doucet J, Bénas P, Fayard B, Delpech M, Grateau G, Riès-Kautt M.

Biophys J. 2011 Jul 20;101(2):486-93. doi: 10.1016/j.bpj.2011.05.055.

6.

Structural and dynamical insights into the opening mechanism of P. aeruginosa OprM channel.

Phan G, Benabdelhak H, Lascombe MB, Benas P, Rety S, Picard M, Ducruix A, Etchebest C, Broutin I.

Structure. 2010 Mar 14;18(4):507-17. doi: 10.1016/j.str.2010.01.018.

7.

Enzyme structural plasticity and the emergence of broad-spectrum antibiotic resistance.

Maurice F, Broutin I, Podglajen I, Benas P, Collatz E, Dardel F.

EMBO Rep. 2008 Apr;9(4):344-9. doi: 10.1038/embor.2008.9. Epub 2008 Feb 22.

8.
9.

Effects of tRNA 3 Lys aminoacylation on the initiation of HIV-1 reverse transcription.

Rigourd M, Bec G, Bénas P, Le Grice SF, Ehresmann B, Ehresmann C, Marquet R.

Biochimie. 2003 May;85(5):521-5.

PMID:
12763311
10.

Strong and specific effects of cations on lysozyme chloride solubility.

Bénas P, Legrand L, Riès-Kautt M.

Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 1):1582-7. Epub 2002 Sep 26.

PMID:
12351866
11.

Growth kinetics, diffraction properties and effect of agarose on the stability of a novel crystal form of Thermus thermophilus aspartyl-tRNA synthetase-1.

Zhu DW, Lorber B, Sauter C, Ng JD, Bénas P, Le Grimellec C, Giegé R.

Acta Crystallogr D Biol Crystallogr. 2001 Apr;57(Pt 4):552-8.

PMID:
11264584
12.

The crystal structure of HIV reverse-transcription primer tRNA(Lys,3) shows a canonical anticodon loop.

Bénas P, Bec G, Keith G, Marquet R, Ehresmann C, Ehresmann B, Dumas P.

RNA. 2000 Oct;6(10):1347-55.

13.

[Influence of parathyroidectomy on the anemia of hemodialysis patients (author's transl)].

Olmer M, Benas P, Elbet M, Ducros J, Salvadori JM.

Nephrologie. 1980;1(1):15-7. French.

PMID:
7301014
14.

[Anemia in chronic hemodialysis; comparative value of iron therapy administered by oral and intravenous routes].

Ducros J, Benas P, Salvadori JM, Olmer M.

J Urol Nephrol (Paris). 1977 Sep;83(9):735-8. French. No abstract available.

PMID:
926237

Supplemental Content

Support Center